Multiple doses of anti-SARS-CoV-2 Convalescent Plasma

BIOLOGICAL2 trials

Sponsors

Noah Merin, Hospital Regional Dr. Rafael Estévez

Conditions

COVID-19Covid-19Sars-CoV2

Early Phase 1

Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure

TerminatedNCT04353206

Noah MerinCovid-19, Sars-CoV2

Start: 2020-06-27End: 2020-11-01Updated: 2021-11-08

Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19

CompletedNCT05595538

Hospital Regional Dr. Rafael EstévezCOVID-19

Start: 2020-06-06End: 2020-10-14Updated: 2022-10-27